ArticleChinese journal of cancer research = Chung-kuo yen cheng yen chiu2014

Efficacy of third-line pemetrexed monotherapy versus pemetrexed combination with bevacizumab in patients with advanced EGFR mutation-positive lung adenocarcinoma.

Cheng-Zhi Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.